MOVING AHEAD REQUIRES A SURE PATH FORWARD

Trials are inherently risky, and every detail matters. We spot risks before they become problems to help you avoid costly delays through an array of solutions that provide confidence at every turn.

ENHANCE TRIAL OVERSIGHT

Run more efficient trials by unlocking hidden insights
Learn More

enable site optimization

Generate high-quality data by optimizing site selection and performance
Learn More

increase patient engagement

Equip patients with the tools to take control of their health
Learn More

ensure safety and measure efficacy

By driving high-quality data
Learn More

THE ERT EXPERT PLATFORM

The ERT EXPERT® platform is the underlying proprietary technology that powers all ERT solutions. Improve trial visibility and performance and reduce time-to-market with confidence, agility and acceleration.

MINIMIZe RISK AND UNCERTAINTY

We enable the flexibility and adaptability you need to accelerate through hurdles for faster speed to market. Here’s how:

 

235k investigative sites supported

Every trial runs into unexpected challenges. With more than 13,000 trials under our belt, we’ve seen most of them before and have the expertise to put your trial back on course.

 

13K+
Trials supported
25 ready-to-launch analytics tools

We’ll protect the success of your trial before there’s ever an issue, with near real-time access to study, program and enterprise-level performance.

 

3M+
global patients supported

NEWS & EVENTS 

LATEST NEWS

VOICE 2018

Clinical trials must modernize across many fronts including better patient engagement, more accurate data collection and new data streams. Learn how voice technology, including artificial intelligence, voice assistance and natural language processing improves all of these efforts.

Electronic Platforms Drive Improvements in Vaccine Study Efficiency and Data Quality

Read this article to learn how the latest electronic data capture solutions are helping to deliver safe and effective vaccines faster and more cost-effectively.


Navigating the Response Assessment Criteria for Lymphoma

Learn how recent changes to the standard treatment response criteria used in lymphoma clinical trials ─ including new biomarkers and different imaging methods ─ are enabling more accurate and effective patient assessment and management.